[Federal Register Volume 88, Number 16 (Wednesday, January 25, 2023)]
[Notices]
[Page 4850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01371]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Subcutaneous Drug Development & Delivery 
Consortium, Inc.

    Notice is hereby given that, on December 21, 2022, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Subcutaneous Drug 
Development & Delivery Consortium, Inc. (``Subcutaneous Drug 
Development & Delivery Consortium, Inc.'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Biogen Inc., 
Cambridge, MA; C.H. Boehringer Sohn AG & Co. KG, Ridgefield, CT; 
Kal[eacute]o, Inc., Richmond, VA; KORU Medical Systems, Mahwah, NJ; 
NEMERA La Verpilliere SAS, La Verpilliere, FRANCE; and Comera Life 
Sciences, Woburn, MA, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Subcutaneous Drug Development & 
Delivery Consortium, Inc. intends to file additional written 
notifications disclosing all changes in membership.
    On October 26, 2020, Subcutaneous Drug Development & Delivery 
Consortium, Inc. filed its original notification pursuant to Section 
6(a) of the Act. The Department of Justice published a notice in the 
Federal Register pursuant to Section 6(b) of the Act on December 3, 
2020 (85 FR 78148).
    The last notification was filed with the Department on April 25, 
2022. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on May 13, 2022 (87 FR 29381).

Suzanne Morris,
Deputy Director of Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2023-01371 Filed 1-24-23; 8:45 am]
BILLING CODE P